title: Enhanced sympathetic activity and cardiac sympathetic afferent reflex in rats with heart failure induced by adriamycin.
abstract: Our previous studies have shown that the cardiac sympathetic afferent reflex is enhanced in rats with chronic heart failure (CHF) induced by coronary artery ligation and contributes to the over-excitation of sympathetic activity. We sought to determine whether sympathetic activity and cardiac sympathetic afferent reflex were enhanced in adriamycin-induced CHF and whether angiotensin II (Ang II) in the paraventricular nucleus (PVN) was involved in enhancing sympathetic activity and cardiac sympathetic afferent reflex. Heart failure was induced by intraperitoneal injection of adriamycin for six times during 2 weeks (15 mg/kg). Six weeks after the first injection, the rats underwent anesthesia with urethane and α-chloralose. After vagotomy and baroreceptor denervation, cardiac sympathetic afferent reflex was evaluated by renal sympathetic nerve activity and mean arterial pressure (MAP) response to epicardial application of capsaicin (1.0 nmol). The response of MAP to ganglionic blockade with hexamethonium in conscious rats was performed to evaluate sympathetic activity. The renal sympathetic nerve activity and cardiac sympathetic afferent reflex were enhanced in adriamycin rats and the maximum depressor response of MAP induced by hexamethonium was significantly greater in adriamycin rats than that in control rats. Bilateral PVN microinjection of angiotensin II (Ang II) caused larger responses of the cardiac sympathetic afferent reflex, baseline renal sympathetic nerve activity and MAP in adriamycin rats than control rats. These results indicated that both sympathetic activity and cardiac sympathetic afferent reflex were enhanced and Ang II in the PVN was involved in the enhanced sympathetic activity and cardiac sympathetic afferent reflex in rats with adriamycin-induced heart failure.
authors.affiliation: Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu 210029, China.
authors.forename: Shujuan
authors.initials: S
authors.lastname: Zhang
authors.forename: Feng
authors.initials: F
authors.lastname: Zhang
authors.forename: Haijian
authors.initials: H
authors.lastname: Sun
authors.forename: Yebo
authors.initials: Y
authors.lastname: Zhou
authors.forename: Ying
authors.initials: Y
authors.lastname: Han
keywords: adriamycin; angiotensin II; heart failure; paraventricular nucleus; sympathetic activity
references.citation: Cancer. 1973 Aug;32(2):302-14
references.pmid: 4353012
references.citation: Circulation. 1994 Jun;89(6):2829-35
references.pmid: 8205698
references.citation: PLoS One. 2011;6(10):e25784
references.pmid: 21991351
references.citation: Eur J Heart Fail. 2007 Oct;9(10):967-73
references.pmid: 17719272
references.citation: Am J Pathol. 1997 Feb;150(2):727-34
references.pmid: 9033285
references.citation: Circulation. 2001 Sep 18;104(12 Suppl 1):I213-7
references.pmid: 11568058
references.citation: Exp Physiol. 2008 Jun;93(6):746-53
references.pmid: 18281391
references.citation: Hypertension. 1987 Jan;9(1):81-7
references.pmid: 2878880
references.citation: Life Sci. 2004 Dec 17;76(5):585-97
references.pmid: 15556170
references.citation: Clin Exp Pharmacol Physiol. 2001 Jan-Feb;28(1-2):95-9
references.pmid: 11153547
references.citation: J Mol Cell Cardiol. 2004 Oct;37(4):837-46
references.pmid: 15380674
references.citation: Pflugers Arch. 2011 Apr;461(4):437-46
references.pmid: 21340460
references.citation: Am J Physiol. 1991 Mar;260(3 Pt 2):H909-16
references.pmid: 2000986
references.citation: Am J Physiol. 1990 Feb;258(2 Pt 2):R425-9
references.pmid: 2309935
references.citation: J Clin Invest. 1980 Jan;65(1):128-35
references.pmid: 7350193
references.citation: Auton Neurosci. 2005 Aug 31;121(1-2):56-63
references.pmid: 16099221
references.citation: J Appl Physiol (1985). 2007 Jan;102(1):9-10
references.pmid: 16990500
references.citation: Hypertension. 2002 Jan;39(1):63-8
references.pmid: 11799080
references.citation: Int J Cardiol. 2007 Apr 12;117(1):6-15
references.pmid: 16863672
references.citation: J Appl Physiol (1985). 2011 Mar;110(3):646-52
references.pmid: 21164151
references.citation: PLoS One. 2011 Jan 31;6(1):e14633
references.pmid: 21297953
references.citation: Hypertension. 2007 Aug;50(2):360-7
references.pmid: 17576857
references.citation: Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1828-35
references.pmid: 15371269
references.citation: Cancer Res. 1983 Feb;43(2):460-72
references.pmid: 6293697
references.citation: Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2039-45
references.pmid: 12003809
references.citation: Basic Res Cardiol. 2002 Jul;97(4):320-6
references.pmid: 12111042
references.citation: J Appl Physiol (1985). 2004 Nov;97(5):1746-54
references.pmid: 15475555
references.citation: Int J Cardiol. 2009 May 1;134(1):82-90
references.pmid: 18619688
references.citation: Heart Fail Rev. 2000 Mar;5(1):57-71
references.pmid: 16228916
references.citation: J Mol Cell Cardiol. 2004 May;36(5):683-90
references.pmid: 15135663
references.citation: Hypertension. 1980 Jul-Aug;2(4):408-18
references.pmid: 7399624
references.citation: Heart Fail Monit. 2002;3(1):2-7
references.pmid: 12634882